[{"address1": "Calle Jos\u00e9 Isbert, 2", "address2": "Pozuelo de Alarc\u00f3n", "city": "Madrid", "zip": "28223", "country": "Spain", "phone": "34 91 021 30 00", "website": "https://www.rovi.es", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmace\u00faticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.", "fullTimeEmployees": 2137, "companyOfficers": [{"maxAge": 1, "name": "Mr. Juan  Lopez-Belmonte Encina", "title": "Chairman & CEO", "fiscalYear": 2023, "totalPay": 1303250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ivan  Lopez-Belmonte Encina", "title": "Second Deputy Chairman & GM of Commercial and Development", "fiscalYear": 2023, "totalPay": 527559, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Javier  Lopez-Belmonte Encina", "title": "First Deputy Chairman, GM of Industrial Operations & CFO", "fiscalYear": 2023, "totalPay": 529795, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Marta Campos Mart\u00ednez", "title": "Head of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mercedes Ben\u00edtez del Castillo S\u00e1nchez", "title": "Legal Department Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beatriz  \u00c1vila Alcalde", "title": "Sales Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rosario  Perucha P\u00e9rez", "title": "Marketing Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Francisco Javier Angulo Garc\u00eda", "title": "Human Resources Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gabriel  Nunez Fernandez", "title": "Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 1, "shareHolderRightsRisk": 6, "overallRisk": 2, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 90.61, "open": 90.61, "dayLow": 90.61, "dayHigh": 90.61, "regularMarketPreviousClose": 90.61, "regularMarketOpen": 90.61, "regularMarketDayLow": 90.61, "regularMarketDayHigh": 90.61, "dividendRate": 1.19, "dividendYield": 0.013200001, "exDividendDate": 1720396800, "beta": 0.508, "trailingPE": 29.13505, "volume": 100, "regularMarketVolume": 100, "averageVolume": 1, "bid": 85.12, "ask": 90.12, "bidSize": 29200, "askSize": 27000, "marketCap": 4634656256, "fiftyTwoWeekLow": 50.88, "fiftyTwoWeekHigh": 90.61, "priceToSalesTrailing12Months": 5.957142, "fiftyDayAverage": 90.3364, "twoHundredDayAverage": 75.03385, "trailingAnnualDividendRate": 1.104, "trailingAnnualDividendYield": 0.012184085, "currency": "USD", "enterpriseValue": 4717366784, "profitMargins": 0.19028, "floatShares": 18606141, "sharesOutstanding": 51149500, "heldPercentInsiders": 0.60252, "heldPercentInstitutions": 0.19048999, "bookValue": 8.919, "priceToBook": 10.159211, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 0.531, "netIncomeToCommon": 148034000, "trailingEps": 3.11, "enterpriseToRevenue": 6.063, "enterpriseToEbitda": 21.84, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "LABFF", "underlyingSymbol": "LABFF", "shortName": "LABORATORIOS FARMACEUTICOS ROVI", "longName": "Laboratorios Farmaceuticos Rovi, S.A.", "firstTradeDateEpochUtc": 1617629400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "35a3b143-8661-34d0-8bd1-529d1e2b2829", "gmtOffSetMilliseconds": -14400000, "currentPrice": 90.61, "recommendationKey": "none", "totalCash": 45118000, "totalCashPerShare": 0.882, "ebitda": 215996000, "totalDebt": 121159000, "quickRatio": 0.66, "currentRatio": 1.985, "totalRevenue": 778000000, "debtToEquity": 25.097, "revenuePerShare": 14.664, "returnOnAssets": 0.13567, "returnOnEquity": 0.29523, "freeCashflow": 15221750, "operatingCashflow": 90457000, "earningsGrowth": 0.531, "revenueGrowth": -0.006, "grossMargins": 0.60515, "ebitdaMargins": 0.27763, "operatingMargins": 0.2086, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]